Back to Screener

Healthcare

Swedish Orphan Biovitrum AB(BIOVF)

Live Price

Offline

$48.00

+0.00% today

1Y Change

+64.10%

Window

Jun 26, 2025 โ†’ Jun 25, 2026

Market Cap
$150.10B
Revenue Growth
+8.2%
EPS Growth
-87.8%
Dividend Yield
0.0%

Coverage: 250 bars ยท Jun 26, 2025 โ†’ Jun 25, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Swedish Orphan Biovitrum AB (BIOVF) is a Healthcare stock with a market cap of $150.10B and listed on OTC. The stock last traded around $48.00 and up 64.1% across the available one-year price window (Jun 26, 2025 โ†’ Jun 25, 2026). Baseline metrics include revenue growth of +8.2%, EPS growth of -87.8%, a dividend yield of 0.0%. What stands out right now is revenue +8.2%, EPS -87.8%, free cash flow +94.0% with operating margin 29.6% and ROIC 12.1%. Valuation already assumes a fairly strong business story at P/E 162.9 and price/sales 5.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines BIOVF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

BIOVF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

BIOVF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

BIOVF Max Drawdown

-5.11%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for BIOVF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedApr 28, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Apr 28, 26
โ€”
Est 0.38
โ€”
โ€”
Est 748879.4B
โ€”
Apr 28
โ€”
Feb 5, 26
โœ“
0.60
Est 0.46
+31.4%
846232.2B
Est 863398.1B
-2.0%
Feb 5
โ€”
Oct 20, 25
โœ“
0.64
Est 0.49
+29.9%
823478.4B
Est 875556.2B
-6.0%
Oct 20
โ€”
Jul 16, 25
โœ“
0.24
Est 0.18
+35.6%
645225.8B
Est 813607.7B
-20.7%
Jul 16
โ€”
Apr 29, 25
โœ“
0.26
Est 0.22
+20.8%
645796.7B
Est 645923.8B
-0.0%
Apr 29
โ€”
Feb 5, 25
โœ“
0.37
Est 0.32
+14.4%
669240.0B
Est 561823.5B
+19.1%
Feb 5
โ€”
Oct 24, 24
โœ“
0.40
Est 0.22
+84.8%
664462.7B
Est 590985.2B
+12.4%
Oct 24
โ€”
Jul 16, 24
โœ—
0.07
Est 0.07
-2.5%
514870.8B
Est 477477.8B
+7.8%
Jul 16
โ€”
Apr 25, 24
โœ“
0.26
Est 0.22
+18.8%
576803.2B
Est 531071.2B
+8.6%
Apr 25
โ€”
Feb 8, 24
โœ—
0.30
Est 0.56
-46.4%
676959.6B
Est 671135.3B
+0.9%
Feb 8
โ€”
Oct 30, 23
โœ—
0.05
Est 0.09
-44.4%
469137.3B
Est 415071.5B
+13.0%
Oct 30
โ€”
Jul 18, 23
โœ“
0.14
Est 0.11
+27.3%
449025.4B
Est 408229.1B
+10.0%
Jul 18
โ€”
Apr 27, 23
โœ“
0.34
Est 0.22
+54.5%
503368.4B
Est 498342.9B
+1.0%
Apr 27
โ€”
Feb 8, 23
โœ“
0.44
Est 0.44
+0.2%
584897.5B
Est 538180.9B
+8.7%
Feb 8
โ€”
Oct 27, 22
โœ“
0.14
Est 0.12
+19.5%
356903.4B
Est 354320.2B
+0.7%
Oct 27
โ€”
Jul 19, 22
โœ“
0.08
Est 0.06
+38.7%
376764.0B
Est 345777.5B
+9.0%
Jul 19
โ€”
Apr 28, 22
โœ“
0.39
Est 0.29
+33.8%
524914.7B
Est 477864.0B
+9.8%
Apr 28
โ€”
Feb 10, 22
โœ“
0.45
Est 0.37
+22.6%
539676.3B
Est 524946.4B
+2.8%
Feb 10
โ€”
Oct 22, 21
โœ“
0.18
Est 0.15
+22.3%
428327.8B
Est โ€”
โ€”
Oct 22
โ€”
Jul 21, 21
โœ“
0.10
Est 0.07
+38.4%
374263.5B
Est โ€”
โ€”
Jul 21
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener